NCT04063709View on ClinicalTrials.gov

Transcutaneous ARFI Ultrasound for Differentiating Carotid Plaque With High Stroke Risk

NAActive, not recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 17, 2019

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
Plaque, AtheroscleroticCarotid Artery PlaqueCarotid Stenosis
Interventions
DIAGNOSTIC_TEST

Acoustic Radiation Force Impulse (ARFI) ultrasound

ARFI imaging is an ultrasound-based, noninvasive imaging method and will be used in accordance with approved labeling.

Trial Locations (1)

27599

The University of North Carolina at Chapel Hill Hospitals, Chapel Hill

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of North Carolina, Chapel Hill

OTHER

NCT04063709 - Transcutaneous ARFI Ultrasound for Differentiating Carotid Plaque With High Stroke Risk | Biotech Hunter | Biotech Hunter